Home / VS : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does VS make money? Does VS have pricing power? What's the Earnings Whisper? Will VS profit more as the business scales? What is VS's management track record? Is VS's current price justified?

Versus Systems Inc.

$1.11 -$0.14 (-11.20%)

NASDAQ · 15 Sep 2026 18:01 UTC

Previous Close

$1.03

Day Range

$1.06$1.21

Year Range

$0.75$2.47

Market Cap

5.44M

AVG Volume

37.48K

Trailing/Forward PE

-2.35/-

PEG ratio

0.18

Dividend Yield

Next Earnings Date

2026-11-17

Primary Exchange

NASDAQ

Revenue (USD)

VS Revenue (USD) by year
Period	Revenue (USD)
2025	2.18M
2024	57.3K
2023	271.16K
2022	1.11M
2021	765.15K
2020	1.81M
2019	650.74K
2018	1.19K
2017	0
2016	0

Net Income (USD)

VS Net Income (USD) by year
Period	Net Income (USD)
2025	-2M
2024	-3.74M
2023	-10.47M
2022	-20.08M
2021	-18.01M
2020	-7.55M
2019	-5.76M
2018	-3.37M
2017	-3.9M
2016	-2.73M

Operating Income (USD)

VS Operating Income (USD) by year
Period	Operating Income (USD)
2025	-2.46M
2024	-4.54M
2023	-10.8M
2022	-22.06M
2021	-14M
2020	-9.81M
2019	-6.12M
2018	-7.59M
2017	-4.8M
2016	-2.79M

EBITDA (USD)

VS EBITDA (USD) by year
Period	EBITDA (USD)
2025	-2.46M
2024	-3.62M
2023	-4.27M
2022	-18.78M
2021	-18.28M
2020	-7.25M
2019	-5.25M
2018	-4.57M
2017	-4.86M
2016	-2.75M

Cash Flows (USD)

VS Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-2.38M
2024	-4.93M
2023	-5.55M
2022	-11.13M
2021	-11.16M
2020	-5.09M
2019	-5.04M
2018	-5.08M
2017	-3.78M
2016	-1.71M

EPS (USD)

VS EPS (USD) by year
Period	EPS (USD)
2025	-0.48
2024	-1.46
2023	-11.21
2022	-196.01
2021	-301.27
2020	-197.2
2019	-219.66
2018	-209.26
2017	-221.51
2016	-14.83

Expenses (USD)

VS Expenses (USD) by year
Period	Expenses (USD)
2025	4.64M
2024	4.56M
2023	7.71M
2022	8M
2021	7.9M
2020	5.53M
2019	5.96M
2018	5.74M
2017	5.56M
2016	2.92M

Cash & Debt (USD)

VS Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	527.39K
2024	4.41M
2023	4.69M
2022	1.6M
2021	1.68M
2020	2.91M
2019	99.17K
2018	24.96K
2017	183.49K
2016	900.53K

Debt ratios

VS Debt ratios by year
Period	Debt ratios
2025	0.02
2024	0.1
2023	0.1
2022	-0.04
2021	-0.04
2020	-0.17
2019	-0.33
2018	-0.2

Margins

VS Margins by year
Period	Margins
2025	99.25%
2024	29.72%
2023	70.69%
2022	45.85%
2021	40.61%
2020	103.98%
2019	-63.34%
2018	-126427.17%

Return on Capital

VS Return on Capital by year
Period	Return on Capital
2025	-104.4%
2024	-74.22%
2023	-229.86%
2022	-313.2%
2021	-128.61%
2020	521.25%
2019	200.59%
2018	550.03%
2017	-130.2%
2016	-57.85%

Shares Outstanding

VS Shares Outstanding by year
Period	Shares Outstanding
2025	4.9M
2024	3.26M
2023	1.55M
2022	103.77K
2021	63.56K
2020	41.66K
2019	35.23K
2018	23.82K
2017	19.99K
2016	272.54K

Book Value Per Share (USD)

VS Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	0.39
2024	1.55
2023	2.94
2022	61.77
2021	220.31
2020	-34.77
2019	-81.47
2018	-25.75
2017	149.99
2016	17.29

Total Assets (USD)

VS Total Assets (USD) by year
Period	Total Assets (USD)
2025	2.06M
2024	5.08M
2023	4.88M
2022	10.91M
2021	18.54M
2020	6.99M
2019	4.04M
2018	2.7M
2017	3.97M
2016	4.96M

Employee Count

VS Employee Count by year
Period	Employee Count
2025	5
2024	16
2023	8
2022	18

Free Cash Flow Yield

VS Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-23.05%
Sep 26	-21.01%
Sep 26	-19.79%
Aug 26	-18.85%
Aug 26	-18.55%
Aug 26	-16.84%
Aug 26	-24.9%
Jul 26	-26.1%
Jul 26	-23.47%
Jul 26	-21.18%
Jul 26	-21.89%
Jul 26	-24.71%
Jun 26	-26.1%
Jun 26	-26.31%
Jun 26	-23.47%
Jun 26	-22.04%
May 26	-22.04%
May 26	-30.49%
May 26	-28.12%
May 26	-39.87%
May 26	-36.3%
Apr 26	-41.94%
Apr 26	-40.2%
Apr 26	-41.24%
Apr 26	-40.87%
Mar 26	-38.44%
Mar 26	-41.24%
Mar 26	-42.39%
Mar 26	-49.83%
Feb 26	-54.26%
Feb 26	-53.18%
Feb 26	-45.71%
Feb 26	-41.62%
Jan 26	-37.49%
Jan 26	-35.72%
Jan 26	-36%
Jan 26	-35.72%
Jan 26	-36.29%
Dec 25	-36%
Dec 25	-35.16%
Dec 25	-35.72%
Dec 25	-34.63%
Nov 25	-30.24%
Nov 25	-30.86%
Nov 25	-31.94%
Nov 25	-32.52%
Oct 25	-28.08%
Oct 25	-26.48%
Oct 25	-27.8%
Oct 25	-26.1%
Oct 25	-26.1%
Sep 25	-27.26%
Sep 25	-28.37%
Sep 25	-26.73%
Sep 25	-28.51%
Aug 25	-28.51%
Aug 25	-29.26%
Aug 25	-24.28%
Aug 25	-34.61%
Aug 25	-35.23%
Jul 25	-32.72%
Jul 25	-28.31%
Jul 25	-30.06%
Jul 25	-31.27%
Jun 25	-35.23%
Jun 25	-32.85%
Jun 25	-36.05%
Jun 25	-34.3%
May 25	-37.26%
May 25	-39.33%
May 25	-39.53%
May 25	-76.34%
May 25	-74.09%
Apr 25	-74.46%
Apr 25	-76.34%
Apr 25	-71.63%
Apr 25	-79.55%
Mar 25	-101.25%
Mar 25	-104.7%
Mar 25	-98.01%
Mar 25	-96.69%
Feb 25	-101.73%
Feb 25	-104.7%
Feb 25	-107.32%
Feb 25	-101.73%
Jan 25	-93.73%
Jan 25	-78.34%
Jan 25	-77.77%
Jan 25	-105.74%
Jan 25	-92.12%
Dec 24	-94.14%
Dec 24	-98.46%
Dec 24	-124.79%
Dec 24	-124.79%
Nov 24	-140.29%
Nov 24	-130.09%
Nov 24	-141.21%
Nov 24	-130.47%
Nov 24	-117.75%
Oct 24	-94.49%

Price to Sales

VS Price to Sales by year
Period	Price to Sales
Sep 26	3.38
Sep 26	3.7
Sep 26	3.93
Aug 26	4.13
Aug 26	4.2
Aug 26	4.62
Aug 26	3.21
Jul 26	3.06
Jul 26	3.4
Jul 26	3.77
Jul 26	3.65
Jul 26	3.23
Jun 26	3.06
Jun 26	3.04
Jun 26	3.4
Jun 26	3.62
May 26	3.62
May 26	2.62
May 26	2.84
May 26	2.74
May 26	3.01
Apr 26	2.6
Apr 26	2.72
Apr 26	2.47
Apr 26	2.5
Mar 26	2.65
Mar 26	2.47
Mar 26	2.41
Mar 26	2.05
Feb 26	1.88
Feb 26	1.92
Feb 26	2.23
Feb 26	2.45
Jan 26	2.72
Jan 26	2.86
Jan 26	2.83
Jan 26	2.86
Jan 26	2.81
Dec 25	2.83
Dec 25	2.9
Dec 25	2.86
Dec 25	2.95
Nov 25	3.37
Nov 25	3.31
Nov 25	3.19
Nov 25	3.84
Oct 25	4.45
Oct 25	4.71
Oct 25	4.49
Oct 25	4.78
Oct 25	4.78
Sep 25	4.58
Sep 25	4.4
Sep 25	4.67
Sep 25	4.38
Aug 25	4.38
Aug 25	4.27
Aug 25	5.14
Aug 25	47.92
Aug 25	47.06
Jul 25	50.68
Jul 25	58.56
Jul 25	55.16
Jul 25	53.03
Jun 25	47.06
Jun 25	50.47
Jun 25	46
Jun 25	48.34
May 25	44.51
May 25	42.17
May 25	41.95
May 25	112.77
May 25	116.19
Apr 25	115.62
Apr 25	112.77
Apr 25	120.18
Apr 25	108.22
Mar 25	58.05
Mar 25	56.13
Mar 25	59.97
Mar 25	60.79
Feb 25	57.78
Feb 25	56.13
Feb 25	54.76
Feb 25	57.78
Jan 25	62.71
Jan 25	75.03
Jan 25	75.57
Jan 25	55.59
Jan 25	63.8
Dec 24	62.43
Dec 24	59.69
Dec 24	47.1
Dec 24	47.1
Nov 24	41.89
Nov 24	45.18
Nov 24	41.62
Nov 24	39.88
Nov 24	44.18
Oct 24	55.06

Price to Book

VS Price to Book by year
Period	Price to Book
Sep 26	1.44
Sep 26	1.58
Sep 26	1.68
Aug 26	1.76
Aug 26	1.79
Aug 26	1.97
Aug 26	5.35
Jul 26	5.11
Jul 26	5.68
Jul 26	6.29
Jul 26	6.09
Jul 26	5.39
Jun 26	5.11
Jun 26	5.07
Jun 26	5.68
Jun 26	6.05
May 26	6.05
May 26	4.37
May 26	4.74
May 26	3.12
May 26	3.42
Apr 26	2.96
Apr 26	3.09
Apr 26	1.26
Apr 26	1.27
Mar 26	1.35
Mar 26	1.26
Mar 26	1.23
Mar 26	1.04
Feb 26	0.96
Feb 26	0.98
Feb 26	1.14
Feb 26	1.25
Jan 26	1.39
Jan 26	1.46
Jan 26	1.45
Jan 26	1.46
Jan 26	1.43
Dec 25	1.45
Dec 25	1.48
Dec 25	1.46
Dec 25	1.5
Nov 25	1.72
Nov 25	1.69
Nov 25	1.63
Nov 25	2.2
Oct 25	2.55
Oct 25	2.7
Oct 25	2.57
Oct 25	2.74
Oct 25	2.74
Sep 25	2.63
Sep 25	2.52
Sep 25	2.68
Sep 25	2.51
Aug 25	2.51
Aug 25	2.45
Aug 25	2.95
Aug 25	2.81
Aug 25	2.76
Jul 25	2.97
Jul 25	3.44
Jul 25	3.24
Jul 25	3.11
Jun 25	2.76
Jun 25	2.96
Jun 25	2.7
Jun 25	2.84
May 25	2.61
May 25	2.47
May 25	2.46
May 25	1.28
May 25	1.32
Apr 25	1.31
Apr 25	1.28
Apr 25	1.36
Apr 25	1.23
Mar 25	4.37
Mar 25	4.22
Mar 25	4.51
Mar 25	4.58
Feb 25	4.35
Feb 25	4.22
Feb 25	4.12
Feb 25	4.35
Jan 25	4.72
Jan 25	5.65
Jan 25	5.69
Jan 25	4.18
Jan 25	4.8
Dec 24	4.7
Dec 24	4.49
Dec 24	3.54
Dec 24	3.54
Nov 24	3.15
Nov 24	3.4
Nov 24	3.13
Nov 24	2.45
Nov 24	2.72
Oct 24	3.39

No video analysis for this stock yet. Request one from our team.

News: VS

businesswire.com · 23 Jun 2026

VS-7375 Demonstrates Clinical Activity with a Favorable Safety and Tolerability Profile in TARGET-D 101 Phase 1/2 Clinical Trial in Patients with Advanced KRAS G12D-Mutated Solid Tumors

BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--VS-7375 (investigational KRAS G12D ON/OFF inhibitor) demonstrates clinical activity with a favorable safety profile in TARGET-D 101 clinical trial.

AI Analysis

Versus Systems Inc.

Video analysis: VS

News: VS

VS-7375 Demonstrates Clinical Activity with a Favorable Safety and Tolerability Profile in TARGET-D 101 Phase 1/2 Clinical Trial in Patients with Advanced KRAS G12D-Mutated Solid Tumors

Similar companies